The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil

BACKGROUND: The WHO established targets for 2030 to globally reduce new viral hepatitis B and C infections by 90% and deaths by 65% and recommends searching for coinfections that increase the progression of chronic liver infections towards cirrhosis and hepatocellular carcinoma. AIMS AND METHODOLOGY...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS Negl Trop Dis
Auteurs principaux: Campos, Karoline Rodrigues, Alves, Fabiana Aparecida, Lemos, Marcílio Figueiredo, Moreira, Regina Célia, Marcusso, Rosa Maria Nascimento, Caterino-de-Araujo, Adele
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274452/
https://ncbi.nlm.nih.gov/pubmed/32453768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0008245
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires